These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 12431875

  • 1. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I, Kaynar-Tascioglu J, Kaya B, Goktas P.
    Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
    [Abstract] [Full Text] [Related]

  • 2. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF, Liu CP, Wang NY, Shih SC.
    BMC Infect Dis; 2016 Aug 24; 16(1):444. PubMed ID: 27553962
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.
    García-Rodríguez JA, García Sánchez JE, Muñoz Bellido JL, García Sánchez E, García García MI.
    J Chemother; 1991 Jun 24; 3(3):143-6. PubMed ID: 1919651
    [Abstract] [Full Text] [Related]

  • 4. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I, Kucukercan M, Ceran N.
    Chemotherapy; 2003 Dec 15; 49(6):294-7. PubMed ID: 14671429
    [Abstract] [Full Text] [Related]

  • 6. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ.
    Diagn Microbiol Infect Dis; 2006 Nov 15; 56(3):341-4. PubMed ID: 17049798
    [Abstract] [Full Text] [Related]

  • 7. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Nov 15; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 8. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Apr 15; 42(4):953-5. PubMed ID: 9559819
    [Abstract] [Full Text] [Related]

  • 9. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    J Antimicrob Chemother; 1996 Aug 15; 38(2):287-91. PubMed ID: 8877544
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
    Isenberg HD, Alperstein P, France K.
    Diagn Microbiol Infect Dis; 1999 Feb 15; 33(2):81-6. PubMed ID: 10091030
    [Abstract] [Full Text] [Related]

  • 11. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
    Ermertcan S, Hoşgör M, Tünger O, Coşar G.
    Scand J Infect Dis; 2001 Feb 15; 33(11):818-21. PubMed ID: 11760161
    [Abstract] [Full Text] [Related]

  • 12. The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.
    Louie A, Grasso C, Bahniuk N, Van Scoy B, Brown DL, Kulawy R, Drusano GL.
    Antimicrob Agents Chemother; 2010 Jun 15; 54(6):2646-54. PubMed ID: 20368395
    [Abstract] [Full Text] [Related]

  • 13. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM, Johnson DM, Jones RN.
    J Chemother; 1996 Dec 15; 8(6):411-5. PubMed ID: 8981179
    [Abstract] [Full Text] [Related]

  • 14. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD, Wolter DJ, Wickman PA, Reisbig MD.
    J Antimicrob Chemother; 2006 May 15; 57(5):999-1003. PubMed ID: 16513915
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR, Frei CR, Burgess DS.
    Clin Ther; 2004 Nov 15; 26(11):1800-7. PubMed ID: 15639692
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F, Quentin C.
    Eur J Clin Microbiol Infect Dis; 1997 Feb 15; 16(2):159-62. PubMed ID: 9105845
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP, Pitkin DH, Sheikh W, Nadler HL.
    Clin Infect Dis; 1997 Feb 15; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [Abstract] [Full Text] [Related]

  • 18. In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials.
    Voutsinas D, Mavroudis T, Avlamis A, Giamarellou H.
    J Antimicrob Chemother; 1989 Sep 15; 24 Suppl A():143-7. PubMed ID: 2509412
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA, Blazquez AM, Fresnadillo MJ, Garcia Sanchez E, Garcia Sanchez JE, Trujillano Martin I.
    J Chemother; 1996 Oct 15; 8(5):358-64. PubMed ID: 8957715
    [Abstract] [Full Text] [Related]

  • 20. Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.
    Siqueira VL, Cardoso RF, Caleffi-Ferracioli KR, Scodro RB, Fernandez MA, Fiorini A, Ueda-Nakamura T, Dias-Filho BP, Nakamura CV.
    Antimicrob Agents Chemother; 2014 Jul 15; 58(7):3957-67. PubMed ID: 24798291
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.